Viewing nowCombinationHypoG A Tablet 5/80/20 milligrams
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 202105295 · Approved 2021.07.12
Treatment of essential hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease
This drug is a combination product containing Amlodipine and Valsartan, and is particularly suitable for patients with essential hypertension whose blood pressure is not controlled by single agents. Additionally, the Atorvastatin component reduces the risk of myocardial infarction, stroke, vascular surgeries, and angina in patients with a high risk of cardiovascular disease, and it also helps in the treatment of dyslipidemia. Atorvastatin is effective in controlling cholesterol levels in patients with hypercholesterolemia and mixed dyslipidemia, and is used especially when dietary response is insufficient. This drug improves cardiovascular health by managing blood pressure and blood lipid levels together.
Take 1 tablet once daily with water. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines may switch to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. The medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. - Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. - Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
This drug can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so discontinuation should occur immediately upon confirmation of pregnancy. If muscle-related abnormal symptoms appear or if muscle enzyme levels rise significantly, the drug should be discontinued, and patients at risk of serious myopathy should be particularly cautious. Patients with allergies to any component of this drug, those who are pregnant or breastfeeding, patients with severe liver or kidney disease, and those with certain heart diseases should not take this medication. Patients with sodium or fluid deficits are at risk of hypotension, so their condition should be checked before taking and if hypotensive symptoms occur during treatment, they should seek immediate medical attention. Patients with high serum potassium levels should be cautious when taking this drug alongside potassium-increasing medications, and regular potassium level monitoring is necessary. Patients with vascular problems in the kidneys or those who have received kidney transplants should closely monitor kidney function changes during treatment with this medication. Patients who have undergone heart failure or myocardial infarction should periodically assess kidney function and blood pressure while taking this drug, and should use it cautiously in patients with severe heart failure. Dose adjustment is necessary in patients with poor liver function, and those with a history of liver disease should be aware of symptoms of liver functional abnormalities. Care should be taken as dizziness and fatigue may occur while driving or operating machinery. This drug may interact with various medications, so it's essential to inform a doctor or pharmacist about any other medications being taken, especially certain antibiotics, antifungals, antivirals, and grapefruit juice. This drug is not recommended for breastfeeding women, and Atorvastatin is contraindicated during lactation. If symptoms such as muscle pain, weakness, fever, or malaise occur during treatment, immediate medical attention and testing should be sought. Regular liver function tests and blood tests are required during the use of this drug, and if any abnormal symptoms arise, consult healthcare professionals immediately.
Not everyone experiences these, and they can vary from person to person.
This medication is susceptible to air and humidity, so it should be stored in a tightly closed container. It is important to maintain storage temperatures between 1 to 30 degrees Celsius.
Pale orange oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Dongu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.